SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001619856-23-000079
Filing Date
2023-07-06
Accepted
2023-07-06 08:01:07
Documents
16
Period of Report
2023-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20230629.htm   iXBRL 8-K 44275
2 EX-10.1 crbu-securitiespurchaseagr.htm EX-10.1 210998
3 EX-10.2 crbu-votingagreementxexx102.htm EX-10.2 36521
4 EX-99.1 crbu-20230706xexx991.htm EX-99.1 16786
8 img25401123_0.jpg GRAPHIC 52289
  Complete submission text file 0001619856-23-000079.txt   577678

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20230629.xsd EX-101.SCH 1910
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20230629_lab.xml EX-101.LAB 25850
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20230629_pre.xml EX-101.PRE 13587
10 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20230629_htm.xml XML 4429
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 231072125
SIC: 2836 Biological Products, (No Diagnostic Substances)